Patent details

EP1075264 Title: NEW DRUG COMBINATIONS OF REBOXETINE AND PINDOLOL

Basic Information

Publication number:
EP1075264
PCT Application Number:
PCT/US/1999/006523
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP999173099
PCT Publication Number:
WO/1999/058130
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEW DRUG COMBINATIONS OF REBOXETINE AND PINDOLOL
French Title of Invention:
NOUVELLES COMBINAISON MEDICAMENTEUSES DE LA REBOXETINE, ET DE PINDOLOL
German Title of Invention:
NEUE ARZNEIMITTELKOMBINATIONEN AUS REBOXETIN UND PINDOLOL
SPC Number:

Dates

Filing date:
14/04/1999
Grant date:
01/12/2004
EP Publication Date:
01/12/2004
PCT Publication Date:
18/11/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/02/2001
EP B1 Publication Date:
01/12/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/04/2007
Expiration date:
14/04/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/04/2005
 
 

Name:
Pharmacia & Upjohn Company LLC
Address:
301 Henrietta Street, Kalamazoo, MI 49001, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/12/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
TAYLOR Duncan, Paul
Address:
United States (US)

Priority

Priority Number:
84860 P
Priority Date:
08/05/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/535;
Filing date Document type Number of pages